Cell Therapy Manufacturing Market: Strong Pipeline to Rapidly Surge Growth
As per Future Market Insights’ latest industry analysis, valuation of the global Cell Therapy Manufacturing Market was around US$ 3.3 Billion in 2021, and is projected to exhibit a CAGR of close to 14.2% over the forecast period. The market is expected to reach US$ 13.9 Billion in 2032. Cell therapies are utilized widely to treat viral infections, cancer, hemoglobinopathies, and hereditary immunological disorders. Introduction of reagents and closed system automated equipment for the manufacturing of cellular therapies is an outcome of the increasing research activities in the field of such therapies. A decentralized manufacturing model for clinical trials in cell therapies engaging multiple sites are being favored across the globe. Such instances advocate the treatment of patients using cells, which are produced by utilizing automated equipment at each participating center by considering a single, centrally held in...